Yehuda Handelsman, M.D., F.A.C.P., F.A.C.E., F.N.L.A. is an endocrinologist in private practice, and Medical Director & Principal Investigator of the Metabolic Institute of America.
He is a nationally and internationally-recognized authority on Obesity, insulin resistance, pre-diabetes, and the comprehensive approach to treating diabetes, controlling all cardiovascular risks. He is a pioneer and leader in the understanding of the body’s metabolic and energy systems, fat, and the gut -brain connection. A clinician, researcher and educator, he publishes and lectures extensively.
He is president elect of the American College of Endocrinology; past President of the American Association of Clinical Endocrinologists; and a board member the Pacific Lipid Association. He is Chair, Founder and Program Director of the acclaimed annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease; Associate Editor of the “Journal of Diabetes”; a frequent guest editor for publications such as the “Journal of Clinical Hypertension”; Chair of the AACE 2011 Comprehensive Diabetes Guidelines and its 2014 update committee, member of the AACE 2013 Comprehensive Diabetes Algorithm and the 2012 AACE lipid guideline; he also Co- Chaired consensuses on Diabetes & cancer, insulin resistance and pre-diabetes.
Handelsman has been listed repeatedly in “Top Doctors of Los Angeles,” “Southern California Super Doctors,” and “Best Doctors of America.”